AR107218A1 - Método para producir toxina botulínica - Google Patents

Método para producir toxina botulínica

Info

Publication number
AR107218A1
AR107218A1 ARP160103642A ARP160103642A AR107218A1 AR 107218 A1 AR107218 A1 AR 107218A1 AR P160103642 A ARP160103642 A AR P160103642A AR P160103642 A ARP160103642 A AR P160103642A AR 107218 A1 AR107218 A1 AR 107218A1
Authority
AR
Argentina
Prior art keywords
botulinum toxin
precipitate
buffer
producing
solution
Prior art date
Application number
ARP160103642A
Other languages
English (en)
Inventor
Hye Sul
- Kim Myungseob Young
Chung Sei Kim
Kyoung-Yun Kim
Original Assignee
Daewoong Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daewoong Co Ltd filed Critical Daewoong Co Ltd
Publication of AR107218A1 publication Critical patent/AR107218A1/es

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/36—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving ionic interaction
    • B01D15/361—Ion-exchange
    • B01D15/362—Cation-exchange
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/36—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving ionic interaction
    • B01D15/361—Ion-exchange
    • B01D15/363—Anion-exchange
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D61/00—Processes of separation using semi-permeable membranes, e.g. dialysis, osmosis or ultrafiltration; Apparatus, accessories or auxiliary operations specially adapted therefor
    • B01D61/14—Ultrafiltration; Microfiltration
    • B01D61/145—Ultrafiltration
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D61/00—Processes of separation using semi-permeable membranes, e.g. dialysis, osmosis or ultrafiltration; Apparatus, accessories or auxiliary operations specially adapted therefor
    • B01D61/14—Ultrafiltration; Microfiltration
    • B01D61/147—Microfiltration
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D61/00—Processes of separation using semi-permeable membranes, e.g. dialysis, osmosis or ultrafiltration; Apparatus, accessories or auxiliary operations specially adapted therefor
    • B01D61/58—Multistep processes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/33—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Clostridium (G)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/52—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/24—Metalloendopeptidases (3.4.24)
    • C12Y304/24069—Bontoxilysin (3.4.24.69), i.e. botulinum neurotoxin
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D2315/00—Details relating to the membrane module operation
    • B01D2315/16—Diafiltration

Landscapes

  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Water Supply & Treatment (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Reivindicación 1: Un método para producir toxina botulínica, qua comprende: (a) tratar un cultivo de una cepa productora de toxina botulínica con ácido para formar un precipitado conteniendo toxina botulínica; (b) agregar un tampón al precipitado conteniendo toxina botulínica del paso (a), y luego clarificar mediante uno o más métodos seleccionados del grupo compuesto por filtración en profundidad (FP), microfiltración (MF), ultrafiltración (UF), filtración estéril, cromatografía de membrana (CM) y centrifugación; (c) someter la solución conteniendo toxina botulínica de la etapa (b) a la diafiltración UF en un tampón o disolver un precipitado resultante de la precipitación con sulfato de amonio o precipitado con ácido clorhídrico en un tampón; y (d) someter la dilución de retentado, la solución de precipitado de sulfato de amonio o solución de precipitado de ácido clorhídrico de la etapa (c) a la cromatografía de intercambio aniónico (AEX), purificando de este modo la toxina botulínica.
ARP160103642A 2015-11-30 2016-11-29 Método para producir toxina botulínica AR107218A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020150168196A KR101775682B1 (ko) 2015-11-30 2015-11-30 보툴리눔 독소의 제조방법

Publications (1)

Publication Number Publication Date
AR107218A1 true AR107218A1 (es) 2018-04-11

Family

ID=58797138

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP160103642A AR107218A1 (es) 2015-11-30 2016-11-29 Método para producir toxina botulínica

Country Status (13)

Country Link
US (1) US10619143B2 (es)
EP (1) EP3383889A4 (es)
JP (1) JP6574528B2 (es)
KR (1) KR101775682B1 (es)
CN (1) CN108350043B (es)
AR (1) AR107218A1 (es)
AU (2) AU2016364597B2 (es)
BR (1) BR112018007679A2 (es)
CA (1) CA2997698C (es)
MX (1) MX2018004650A (es)
RU (1) RU2707255C1 (es)
TW (1) TWI623549B (es)
WO (1) WO2017095062A1 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2490986T4 (da) * 2009-10-21 2024-06-17 Revance Therapeutics Inc Fremgangsmåder og systemer til oprensning af ikke-kompleksbundet botulinum-neurotoksin
KR101723168B1 (ko) * 2015-04-28 2017-04-05 주식회사 대웅 보툴리눔 독소의 제조를 위한 배지 조성물
KR102463881B1 (ko) * 2016-10-04 2022-11-07 (주)메디톡스 보툴리눔 독소 함유 용액으로부터 보툴리눔 독소를 분리하는 방법
KR102485146B1 (ko) * 2019-04-15 2023-01-06 (주)제테마 보툴리눔 독소의 제조방법
KR102516203B1 (ko) * 2019-04-15 2023-03-30 (주)제테마 보툴리눔 독소의 제조방법
SG11202111938YA (en) * 2019-05-03 2021-11-29 Genentech Inc Methods of reducing the enzymatic hydrolysis activity rate in a composition obtained from a purification platform
KR102287437B1 (ko) * 2019-08-14 2021-08-09 주식회사 프로톡스 보툴리눔 독소의 제조방법
CN112480221A (zh) * 2020-12-02 2021-03-12 湖北省农业科学院畜牧兽医研究所 产气荚膜梭菌毒素抗原浓缩工艺
KR20230009178A (ko) * 2021-07-08 2023-01-17 주식회사 파마리서치바이오 비-독소 단백질이 제거된 클로스트리디움 보툴리눔 신경독소 단백질의 정제방법

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06192296A (ja) 1992-10-28 1994-07-12 Chiba Pref Gov 治療用医薬品としての結晶ａ型ボツリヌス毒素の製造法。
JPH06199296A (ja) 1992-12-29 1994-07-19 Toyota Motor Corp ガスタービンエンジンを推進力とする水上飛行機
DE19925739A1 (de) 1999-06-07 2000-12-21 Biotecon Ges Fuer Biotechnologische Entwicklung & Consulting Mbh Therapeutikum mit einem Botulinum-Neurotoxin
GB9914743D0 (en) * 1999-06-24 1999-08-25 Knoll Ag Therapeutic agents
US7452697B2 (en) * 2003-09-25 2008-11-18 Allergan, Inc. Chromatographic method and system for purifying a botulinum toxin
CA2556537A1 (en) 2005-03-03 2006-09-03 Allergan, Inc. Media for clostridium bacterium and processes for obtaining a clostridial toxin
KR101025617B1 (ko) 2008-02-25 2011-03-30 메덱스젠 주식회사 클로스트리디움 보툴리눔으로부터 보툴리눔 독소를정제하는 방법
KR20090120222A (ko) * 2008-05-19 2009-11-24 (주)메디톡스 식물 유래 성분 함유 배지 및 가요성 폐쇄 용기를 이용하여클로스트리디움 보툴리눔 독소를 생산하는 방법
US8129139B2 (en) * 2009-07-13 2012-03-06 Allergan, Inc. Process for obtaining botulinum neurotoxin
JP2011074025A (ja) * 2009-09-30 2011-04-14 Chemo-Sero-Therapeutic Research Inst ボツリヌス毒素の精製方法
DK2490986T4 (da) * 2009-10-21 2024-06-17 Revance Therapeutics Inc Fremgangsmåder og systemer til oprensning af ikke-kompleksbundet botulinum-neurotoksin
KR101134146B1 (ko) * 2010-05-31 2012-04-19 메덱스젠 주식회사 국소 근마비 효과를 갖는 비확산형 보툴리눔 독소와 그의 정제방법
UY33452A (es) 2010-06-16 2012-01-31 Bayer Schering Pharma Ag Triazolopiridinas sustituidas
KR101339349B1 (ko) * 2013-08-02 2013-12-09 주식회사 대웅 보툴리눔 독소의 제조방법

Also Published As

Publication number Publication date
RU2707255C1 (ru) 2019-11-25
EP3383889A1 (en) 2018-10-10
EP3383889A4 (en) 2019-07-17
AU2019201315A1 (en) 2019-03-21
TWI623549B (zh) 2018-05-11
CN108350043B (zh) 2022-06-14
US20180251741A1 (en) 2018-09-06
US10619143B2 (en) 2020-04-14
JP2018533977A (ja) 2018-11-22
AU2016364597B2 (en) 2019-01-17
CN108350043A (zh) 2018-07-31
TW201726703A (zh) 2017-08-01
MX2018004650A (es) 2018-08-15
CA2997698C (en) 2021-04-20
KR20170062694A (ko) 2017-06-08
BR112018007679A2 (pt) 2018-11-06
AU2019201315B2 (en) 2020-10-15
WO2017095062A1 (en) 2017-06-08
AU2016364597A1 (en) 2018-04-12
JP6574528B2 (ja) 2019-09-11
CA2997698A1 (en) 2017-06-08
KR101775682B1 (ko) 2017-09-06

Similar Documents

Publication Publication Date Title
AR107218A1 (es) Método para producir toxina botulínica
BR112018016944A2 (pt) composições funcionais derivadas de feijão mungo
JP2018533977A5 (es)
BR112017023912A2 (pt) sistema modular e processo para produção contínua e/ou processamento de um produto de forma desinfectada
BR112016016705A8 (pt) Processo para a purificação de oligossacarídeos neutros de leite humano (hmo), oligossacarídeo de leite humano (hmo) neutro, e uso de um hmo
MX2019000881A (es) Producto lacteo y proceso.
SG11201810044QA (en) Water treatment method and apparatus and method for regenerating ion exchange resin
PH12019500565A1 (en) Containerized desalination system
RU2015120458A (ru) Очистка полипептидов с использованием двухстадийной ультрафильтрации в тангенциальном потоке
WO2015197973A8 (fr) Procédé de traitement d'un flux d'eaux usées par filtration basse pression
WO2016081409A8 (en) Flow control in multi-step filtration, and associated systems
MY170053A (en) Method for producing sugar liquid
CL2015002704A1 (es) Proceso para el tratamiento del agua antes de la osmosis inversa.
JP2017505620A5 (es)
MX2017008409A (es) Sistema y metodo de recuperacion de pintura por electrodeposicion.
IN2015DN00540A (es)
BR112017001039A2 (pt) método para extrair proteínas solúveis de biomassa de microalgas
RU2016124275A (ru) Способ переработки молока
MX2021012522A (es) Metodo de purificacion de la toxina botulinica.
MY180704A (en) Method for improved reactive monomer production with membrane filtration
MX2019007242A (es) Tratamiento de un filtrado proveniente de un biorreactor de membrana anaeorobico (anmbr) con el uso de osmosis inversa o nanofiltracion.
PH12017502299A1 (en) Method for producing a demineralised milk protein composition, suitable in particular for the organic sector, and demineralised milk protein composition
MY183918A (en) A method of recovering rubber from skim natural rubber latex
MY180705A (en) Method for producing sugar solution
JP2017518057A5 (es)

Legal Events

Date Code Title Description
FB Suspension of granting procedure